Regeneron Pharmaceuticals Inc
F:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
F:RGO
|
US |
|
A
|
Air China Ltd
LSE:AIRC
|
CN |
|
BAE Systems PLC
OTC:BAESF
|
UK |
|
Danone SA
LSE:0KFX
|
FR |
|
D
|
Dongfang Electric Corp Ltd
OTC:DNGFF
|
CN |
|
Bank of Communications Co Ltd
F:C4C
|
CN |
|
A
|
Ardelyx Inc
SWB:41X
|
US |
|
C
|
China Life Insurance Co Ltd
F:CLF
|
CN |
|
Z
|
Zoom Video Communications Inc
F:5ZM
|
US |
|
S
|
Sumitomo Electric Industries Ltd
SWB:SMO
|
JP |
|
D
|
DS Smith PLC
F:1KR
|
UK |
|
H
|
HALEON PLC
F:H6D0
|
UK |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 742.82 EUR with a low forecast of 562.06 EUR and a high forecast of 935.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
742.82
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 742.82 EUR with a low forecast of 562.06 EUR and a high forecast of 935.8 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
12%
The compound annual growth rate for Operating Income over the next 8 years is 12%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 8 years is 8%.
